Gubra A/S

Copenhagen Stock Exchange GUBRA.CO

Gubra A/S Gross Profit Margin for the year ending December 31, 2023: 56.06%

Gubra A/S Gross Profit Margin is 56.06% for the year ending December 31, 2023, a 14.36% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Gubra A/S Gross Profit Margin for the year ending December 31, 2022 was 49.02%, a -24.54% change year over year.
  • Gubra A/S Gross Profit Margin for the year ending December 31, 2021 was 64.97%, a 21.21% change year over year.
  • Gubra A/S Gross Profit Margin for the year ending December 31, 2020 was 53.60%.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Copenhagen Stock Exchange: GUBRA.CO

Gubra A/S

CEO Mr. Henrik Blou
IPO Date April 4, 2023
Location Denmark
Headquarters Hørsholm Kongevej 11B
Employees 235
Sector Health Care
Industries
Biotechnology Pharmaceuticals Research & Consulting
Description

Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. The CRO segment offers pre-clinical contract research and development services for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, tissue research, assays, molecular pharmacology, bioanalysis, sequencing (NGS), and 2D and 3D imaging. The company was incorporated in 2008 and is based in Horsholm, Denmark.

StockViz Staff

January 15, 2025

Any question? Send us an email